AMGEN INC (AMGN)
Clinical trial NCT06745323 updates: 1. completion date: 2029-02-09 → 2029-05-10 2. primary completion date: 2029-02-09 → 2029-05-10
Clinical trial NCT06745323 updates: 1. completion date: 2029-02-09 → 2029-05-10 2. primary completion date: 2029-02-09 → 2029-05-10
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical